← Open Payments lookup

ROBERT SWEETEN: Open Payments

NPI 1164509766 · NEOSHO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 38 payments from 13 companies in 2025. Trend: 2023 $815 · 2024 $993 · 2025 $686

Food & beverage: $686
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$146
Novo Nordisk Inc9$139
AstraZeneca Pharmaceuticals LP6$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$31
Abbott Laboratories1$24
Janssen Pharmaceuticals, Inc1$24
Lilly USA, LLC1$21
PFIZER INC.1$20
Axsome Therapeutics, Inc.1$18

Products named: REXULTI, FARXIGA, Ozempic, CAPLYTA, XIFAXAN, FREESTYLE LIBRE, SPRAVATO, ABILIFY MAINTENA.

Industry payments across MO — which companies pay providers there.